Definition/General

Introduction:
-Splenic littoral cell angioma (LCA) is a rare benign vascular tumor unique to the spleen, first described in 1991
-It arises from the littoral cells that line the splenic red pulp sinusoids
-These cells have dual endothelial and histiocytic properties
-LCA accounts for less than 1% of all splenic lesions and represents a distinctive primary splenic neoplasm with characteristic morphologic and immunohistochemical features.
Origin:
-Originates from littoral cells of splenic sinusoids which are specialized cells lining the red pulp sinusoidal spaces
-These cells have unique phenotypic characteristics expressing both endothelial and macrophage markers
-Neoplastic transformation of these cells results in vascular proliferation
-The exact etiology is unknown but may be related to immune dysfunction.
Classification:
-Histologic pattern: Anastomosing vascular channels lined by prominent cells
-By behavior: Benign (typical)
-Borderline (rare cases with atypia)
-By association: Isolated
-Associated with other malignancies (20-30% of cases)
-By presentation: Solitary lesion
-Multiple lesions.
Epidemiology:
-Age distribution: Wide range (17-84 years), median age 55 years
-Gender: Slight male predominance
-Rarity: <50 cases reported in literature
-Association with malignancies: 20-30% of patients have concurrent or subsequent malignancies
-Geographic distribution: No specific geographic predilection.

Clinical Features

Presentation:
-Splenomegaly most common finding (60-70% of patients)
-Asymptomatic in 40-50% of cases (incidental finding)
-Left upper quadrant pain when symptomatic
-Hypersplenism with cytopenia in some cases
-Constitutional symptoms rare unless associated with malignancy.
Symptoms:
-Abdominal symptoms: Left upper quadrant discomfort or pain
-Early satiety due to splenomegaly
-Hematologic symptoms: Fatigue due to anemia
-Easy bruising from thrombocytopenia
-Systemic symptoms: Generally absent unless complicated
-B-symptoms suggest associated malignancy.
Risk Factors:
-Immune dysfunction: Possible association with immune system abnormalities
-Previous malignancy: Some patients have history of other cancers
-Age factor: More common in middle-aged and elderly
-No known environmental or genetic predisposing factors identified.
Screening:
-Cancer surveillance: Important due to association with other malignancies
-Imaging studies: CT or MRI showing splenic lesion
-Laboratory studies: Complete blood count, comprehensive metabolic panel
-Tissue diagnosis: Required for definitive diagnosis
-Multidisciplinary evaluation for associated conditions.

Master Littoral Cell Angioma Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Multiple small nodules scattered throughout splenic parenchyma
-Dark red to purple color similar to blood-filled spaces
-Spongy, soft consistency
-Size range: Few millimeters to several centimeters
-Honeycomb appearance on cut surface due to vascular spaces.
Characteristics:
-Multinodular pattern in most cases (80%)
-Irregular, anastomosing channels grossly visible
-Blood-filled spaces give dark appearance
-No true encapsulation
-May involve entire spleen or be localized to specific areas.
Size Location:
-Diffuse involvement of splenic red pulp in typical cases
-Multiple small lesions: 0.5-5 cm each
-Rarely solitary large mass
-No specific anatomic predilection within spleen
-Associated splenomegaly common.
Multifocality:
-Multifocal lesions in 80-90% of cases
-Bilateral involvement of splenic lobes
-Scattered distribution throughout parenchyma
-No associated lymphadenopathy
-Surrounding splenic tissue may show reactive changes.

Microscopic Description

Histological Features:
-Anastomosing vascular channels lined by prominent littoral cells
-Papillary projections of lining cells into vascular lumina
-Back-to-back arrangement of vascular spaces
-Absence of smooth muscle in vessel walls
-Red blood cells filling vascular spaces.
Cellular Characteristics:
-Littoral cells: Large, plump endothelial-like cells
-Vesicular nuclei with small nucleoli
-Abundant eosinophilic cytoplasm
-Hobnail appearance projecting into lumina
-No significant atypia in typical cases
-Rare mitotic figures.
Architectural Patterns:
-Sinusoidal pattern: Resembles dilated splenic sinusoids
-Papillary pattern: Endothelial projections into lumina
-Anastomosing pattern: Interconnecting vascular channels
-Cavernous areas: Dilated blood-filled spaces
-Solid areas: Dense cellular regions.
Grading Criteria:
-Benign features: Bland cytology, minimal mitoses, organized architecture
-Atypical features: Nuclear pleomorphism, increased mitoses (rare)
-No established grading system: Generally considered benign
-Borderline cases: May show increased cellularity and atypia.

Immunohistochemistry

Positive Markers:
-Endothelial markers: CD31 positive
-Factor VIII positive (variable)
-Histiocytic markers: CD68 positive (characteristic)
-Littoral cell markers: CD21 may be positive
-Other markers: Vimentin positive.
Negative Markers:
-Smooth muscle markers: SMA negative
-Epithelial markers: Cytokeratins negative
-Lymphoid markers: CD45 typically negative
-Melanoma markers: S-100 usually negative
-CD34: May be negative or weakly positive.
Diagnostic Utility:
-Dual phenotype confirmation: CD31+ and CD68+ is characteristic
-Differential diagnosis: Helps distinguish from other vascular lesions
-Littoral cell origin: Unique immunoprofile confirms diagnosis
-Excludes other entities: Negative markers rule out other tumors.
Molecular Subtypes:
-Classical type: CD31+/CD68+ with typical morphology
-Variant patterns: May have different staining intensities
-Associated with malignancy: Same immunoprofile but clinical correlation important
-Borderline lesions: Similar immunoprofile with increased atypia.

Molecular/Genetic

Genetic Mutations:
-Limited molecular data: Few studies on genetic alterations
-Chromosomal abnormalities: No consistent patterns identified
-Tumor suppressor genes: No consistent alterations reported
-Oncogenes: No specific oncogene activation identified.
Molecular Markers:
-Angiogenesis markers: VEGF expression variable
-Cell cycle markers: Low Ki-67 proliferation index
-Apoptosis markers: Normal apoptotic pathways
-Immune markers: May express immune-related proteins.
Prognostic Significance:
-Generally benign: Excellent prognosis after splenectomy
-Association with malignancy: May indicate need for cancer surveillance
-Recurrence: Not reported after complete excision
-No malignant transformation: Benign behavior maintained.
Therapeutic Targets:
-Surgical management: Splenectomy is treatment of choice
-Conservative management: Not recommended due to uncertain behavior
-Surveillance: For associated malignancies
-No specific targeted therapy currently available.

Differential Diagnosis

Similar Entities:
-Splenic hemangioma: Pure vascular tumor without CD68 expression
-Splenic hamartoma: Different architecture and immunoprofile
-Angiosarcoma: Malignant with cytologic atypia
-Peliosis: Cystic blood-filled spaces without lining cells
-Metastatic disease: Different immunoprofile and clinical context.
Distinguishing Features:
-LCA vs hemangioma: CD68+ vs CD68-, different morphology
-LCA vs angiosarcoma: Benign vs malignant cytology, different behavior
-LCA vs hamartoma: Vascular vs red pulp architecture
-Unique immunoprofile: CD31+/CD68+ combination diagnostic.
Diagnostic Challenges:
-Rare entity: Limited experience and literature
-Sampling issues: Multiple lesions require adequate sampling
-Immunohistochemistry essential: Morphology alone may be misleading
-Clinical correlation: Association with malignancies important.
Rare Variants:
-Solitary LCA: Single large lesion instead of multiple nodules
-Atypical LCA: Increased cellularity and atypia
-Sclerosed LCA: Fibrotic areas within lesion
-Mixed patterns: Combination with other splenic lesions
-Pediatric cases: Very rare in children.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

Splenectomy specimen weighing [X] g with multiple nodular lesions

Gross Description

Multiple dark red nodules measuring [size range] distributed throughout splenic parenchyma

Microscopic Findings

Anastomosing vascular channels lined by prominent littoral cells with [morphologic characteristics]

Immunohistochemical Studies

Lining cells positive for CD31 and CD68, negative for smooth muscle actin

Diagnosis

Splenic littoral cell angioma, multifocal

Biologic Behavior

Benign vascular tumor with excellent prognosis after complete excision

Associated Conditions

Associated with other malignancies in 20-30% of patients

Recommendations

Recommend clinical surveillance for associated malignancies and regular follow-up